OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inflammasomes in breast cancer: the ignition spark of progression and resistance?
Sawsan Elgohary, H.M. El Tayebi
Expert Reviews in Molecular Medicine (2023) Vol. 25
Closed Access | Times Cited: 6
Sawsan Elgohary, H.M. El Tayebi
Expert Reviews in Molecular Medicine (2023) Vol. 25
Closed Access | Times Cited: 6
Showing 6 citing articles:
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance
Bifei Fu, YuMing Lou, Pu Wu, et al.
Neoplasia (2024) Vol. 55, pp. 101017-101017
Open Access | Times Cited: 4
Bifei Fu, YuMing Lou, Pu Wu, et al.
Neoplasia (2024) Vol. 55, pp. 101017-101017
Open Access | Times Cited: 4
Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments
Ahmad Dawalibi, Amal Alosaimi, Khalid S. Mohammad
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8163-8163
Open Access | Times Cited: 1
Ahmad Dawalibi, Amal Alosaimi, Khalid S. Mohammad
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8163-8163
Open Access | Times Cited: 1
Unraveling the NLRP Family: Structure, Function, Activation, Critical Influence on Tumor Progression, and Potential as Targets for Cancer Therapy
Xueqing Zhou, Yongguang Tao, Yongyong Shi
Cancer Letters (2024), pp. 217283-217283
Closed Access | Times Cited: 1
Xueqing Zhou, Yongguang Tao, Yongyong Shi
Cancer Letters (2024), pp. 217283-217283
Closed Access | Times Cited: 1
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients
Sawsan Elgohary, Reda A. Eissa, H.M. El Tayebi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14254-14254
Open Access | Times Cited: 4
Sawsan Elgohary, Reda A. Eissa, H.M. El Tayebi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14254-14254
Open Access | Times Cited: 4
Whole transcriptome sequencing indicated the Anti-tumor immunity of NLRP3 in breast cancer
Da Qian, Jie Qiu, Y. Xu, et al.
Genomics (2024) Vol. 116, Iss. 5, pp. 110930-110930
Open Access
Da Qian, Jie Qiu, Y. Xu, et al.
Genomics (2024) Vol. 116, Iss. 5, pp. 110930-110930
Open Access
Role of the NLRP3 inflammasome in gynecological disease
Zheng Xu, Dan Zhao, Ye Jin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115393-115393
Open Access | Times Cited: 1
Zheng Xu, Dan Zhao, Ye Jin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115393-115393
Open Access | Times Cited: 1
